Evidence map›Paper›PMID 33547159›Full record

ArticleCancer research2021

Cancer-Associated Fibroblasts Promote Aggressive Gastric Cancer Phenotypes via Heat Shock Factor 1-Mediated Secretion of Extracellular Vesicles.

Nil Grunberg, Meirav Pevsner-Fischer, Tal Goshen-Lago, Judith Diment, Yaniv Stein, Hagar Lavon, Shimrit Mayer, Oshrat Levi-Galibov, Gil Friedman, Yifat Ofir-Birin and 10 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed, 1 pooled it
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 1 synthesis or guideline pooled it, 111 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. PDPNCell communication and signaling : CCS · 2025
    Article
  9. Article
  10. Review
  11. The fibroinflammatory response in cancer.Nature reviews. Cancer · 2025
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 8 institutions in 3 countries.

Nil GrunbergDepartment of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot, Israel.
Meirav Pevsner-FischerDepartment of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot, Israel.
Tal Goshen-LagoDivision of Oncology, Rambam Health Care Campus, Haifa, Israel.ORCID 0000-0001-6518-4419
Judith DimentDepartment of Pathology, Kaplan Medical Center, Rehovot, Israel.
Yaniv SteinDepartment of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot, Israel.
Hagar LavonDepartment of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot, Israel.
Shimrit MayerDepartment of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot, Israel.
Oshrat Levi-GalibovDepartment of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot, Israel.
Gil FriedmanDepartment of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot, Israel.
Yifat Ofir-BirinDepartment of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot, Israel.
Li-Jyun SyuDepartment of Dermatology, Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.
Cristina MiglioreUniversity of Torino, Department of Oncology, Candiolo; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.ORCID 0000-0003-3722-2814
Eyal ShimoniDepartment of Chemical Research Support, The Weizmann Institute of Science, Rehovot, Israel.
Salomon M StemmerInstitute of Oncology, Davidoff Cancer Center, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.
Baruch BrennerInstitute of Oncology, Davidoff Cancer Center, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.
Andrzej A DlugoszDepartment of Dermatology, Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-9791-3257
David LydenChildren's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, New York.ORCID 0000-0003-0193-4131
Neta Regev-RudzkiDepartment of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot, Israel.
Irit Ben-AharonDivision of Oncology, Rambam Health Care Campus, Haifa, Israel.ORCID 0000-0002-5839-5477
Ruth Scherz-ShouvalDepartment of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot, Israel. ruth.shouval@weizmann.ac.il.
Weizmann Institute of Science · ILMichigan Medicine · USTel Aviv University · ILCandiolo Cancer Institute · ITCornell University · USKaplan Medical Center · ILRambam Health Care Campus · ILTechnion – Israel Institute of Technology · IL

Funding

XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Alexey I Nesvizhskii · 1988 to 2026
$178.2M
University of Michigan Center for Gastrointestinal ResearchP30DK034933 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI OMARY, BISHR · 1986 to 2021
$22.5M
Role of Hedgehog Signaling in Chronic Gastritis and MetaplasiaP01DK062041 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GUMUCIO, DEBORAH L. · 2002 to 2017
$20.6M
MOLECULAR BASIS OF EPITHELIAL SKIN CANCERR01CA087837 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DLUGOSZ, ANDRZEJ A. · 2000 to 2014
$4.9M
Hedgehog signaling in upper digestive tract malignancyR01CA118875 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DLUGOSZ, ANDRZEJ A. · 2007 to 2011
$1.4M
NCI NIH HHS P30 CA046592NCI NIH HHS R01 CA087837NCI NIH HHS R01 CA118875NIDDK NIH HHS P01 DK062041NIDDK NIH HHS P30 DK034933
6 · The paper itself

Abstract

Gastric cancer is the third most lethal cancer worldwide, and evaluation of the genomic status of gastric cancer cells has not translated into effective prognostic or therapeutic strategies. We therefore hypothesize that outcomes may depend on the tumor microenvironment (TME), in particular, cancer-associated fibroblasts (CAF). However, very little is known about the role of CAFs in gastric cancer. To address this, we mapped the transcriptional landscape of human gastric cancer stroma by microdissection and RNA sequencing of CAFs from patients with gastric cancer. A stromal gene signature was associated with poor disease outcome, and the transcription factor heat shock factor 1 (HSF1) regulated the signature. HSF1 upregulated inhibin subunit beta A and thrombospondin 2, which were secreted in CAF-derived extracellular vesicles to the TME to promote cancer. Together, our work provides the first transcriptional map of human gastric cancer stroma and highlights HSF1 and its transcriptional targets as potential diagnostic and therapeutic targets in the genomically stable tumor microenvironment. SIGNIFICANCE: This study shows how HSF1 regulates a stromal transcriptional program associated with aggressive gastric cancer and identifies multiple proteins within this program as candidates for therapeutic intervention. GRAPHICAL ABSTRACT: http://cancerres.aacrjournals.org/content/canres/81/7/1639/F1.large.jpg.

Indexed as

AnimalsCancer-Associated FibroblastsCells, CulturedCohort StudiesDisease ProgressionExtracellular VesiclesHeat Shock Transcription FactorsHumansMiceMice, 129 StrainMice, Inbred BALB CMice, TransgenicNeoplasm InvasivenessPhenotypePrognosisSecretory PathwayHeat Shock Transcription FactorsHSF1 protein, human

Identifiers

PMID33547159
PMCPMC8337092
OpenAlexW3127167528

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.